Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens

Li LF, Qi R, Wei TT, Feng L, Zhang X, Liu Q

Risk Management and Healthcare Policy 2024, 17:927-933

Published Date: 12 April 2024